Sat.Mar 30, 2024 - Fri.Apr 05, 2024

article thumbnail

CDC to doctors: Look out for bird flu infections among dairy farm workers

STAT

The Centers for Disease Control and Prevention urged medical practitioners on Friday to be on the lookout for people who might have contracted H5N1 bird flu from cows. The agency also urged state health departments to rapidly assess any suspected human cases, and recommended that dairy farms with confirmed or suspected outbreaks require workers to use personal protective equipment.

364
364
article thumbnail

As antimicrobial resistance looms large, a nonprofit teams up with Big Pharma to intervene

PharmaVoice

AMR is a growing threat, but with little financial incentive to pick up the torch, government and nonprofit collaborations are keeping the R&D flames burning.

325
325
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

SAEM Clinical Images Series: Red Rash on My Legs

ALiEM - Pharm Pearls

A 23-year-old female with no known past medical history presented with a rash concentrated on her legs, with a few areas on her arms and chest. The rash began the day before presentation when she became overheated while wearing sweatpants in 104°F weather. The rash was mildly pruritic but not painful. She denied any prior reaction to her sweatpants that she has had for several months.

189
189
article thumbnail

ICR collaboration forms national NHS patient database registry for Lynch syndrome patients

Pharma Times

The genetic condition affects one in 279 people in England and significantly increases cancer risk

151
151
article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

article thumbnail

Why a leading bird flu expert isn’t convinced that the risk H5N1 poses to people has declined

STAT

News that H5N1 avian influenza has breached another mammalian species — this time dairy cows — has taken the flu science community aback. Though cows previously had been seen to be susceptible to human flu viruses , and could be experimentally infected with H5 in a lab, the absence of cow involvement until now in H5’s nearly 30-year history lulled scientists into thinking the species was outside the virus’s remit.

363
363
article thumbnail

With a rise in animal-human organ transplants, a drugmaker aims for a new standard of care

PharmaVoice

Eledon Therapeutics is developing a drug that could facilitate organ transplants from animals to humans as the procedure gains steam.

313
313

More Trending

article thumbnail

Ending the silence: Why the menopause matters in the workplace

pharmaphorum

Discover the importance of addressing menopause in the workplace and the benefits of hormone replacement therapy (HRT) through this insightful and informative article on breaking the stigma.

114
114
article thumbnail

Your dog is probably on Prozac. Experts say that says more about the American mental health crisis than pets

STAT

Dogs, our sunny, selfless shadows, crave little more than a daily walk, a treat or two, and their human’s happiness. But increasingly, their own happiness is the topic of concern in veterinarian offices, dog parks, and internet forums. Prozac prescriptions for dogs are on the rise, veterinarians across the country acknowledge, along with a myriad of cheaper generic mood stabilizers sold for humans but applied to pets’ separation anxiety, socialization fears, biting habits, or other

360
360
article thumbnail

To advance women’s leadership, an effort ‘has to be purposeful,’ says EMD Serono exec

PharmaVoice

Gender diversity in leadership “doesn’t just happen,” — it requires institutional change, from investing in women’s startups to providing more generous family leave.

255
255
article thumbnail

A step towards global harmonisation of GMP inspection protocols

Express Pharma

In a letter dated March 21, the US FDA India office country director Sarah McMullen said that four states (Gujarat, Telangana, Goa and Karnataka) had been ‘sensitised to FDA’s inspection process and, as such, are eligible for inclusion as observers for relevant inspection in their respective states.’ The letter goes on to mention, ‘We would appreciate relevant opportunities being made available to state inspectors to attend as observers as practical.’ US FDA’s ̵

110
110
article thumbnail

5 Reasons to Upgrade Your Pharmacy Management Software

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

article thumbnail

AI-powered real-world evidence generation for biotechs

pharmaphorum

Discover how AI-powered real-world evidence generation is revolutionising the biotech industry, providing valuable insights for biopharma companies to make informed decisions. Learn more about the impact of RWD on biotechs.

109
109
article thumbnail

Parkinson’s disease may be helped by GLP-1 drug, new study finds

STAT

The booming class of GLP-1 drugs that includes Ozempic and Wegovy is not only effective for diabetes and obesity, but is also showing early potential to help with conditions involving the brain, like mental health disorders , Alzheimer’s, and even, as new study results suggest — Parkinson’s disease. In a Phase 2 trial, patients with early Parkinson’s disease taking an older GLP-1 diabetes drug called lixisenatide experienced no worsening of motor symptoms over a year,

Diabetes 362
article thumbnail

A dementia-focused VC digs past anti-amyloid for neuroscience diamonds in the rough

PharmaVoice

Even as new drugs like Eisai and Biogen’s Leqembi make a splash in Alzheimer’s, VCs like the Dementia Discovery Fund have invested in the next wave of therapies.

162
162
article thumbnail

Active cooperation among APAC pharma companies gaining traction: GlobalData

Express Pharma

In the dynamic landscape of the pharma industry, collaboration often serves as the key to innovation and expanding market presence. In recent years, the Asia-Pacific (APAC) market has emerged as a hub for pharmaceutical development and investment, attracting attention from both local and global players. While cooperation between APAC-based pharmaceutical companies and their global counterparts has been on the rise, active cooperation among pharma companies within the APAC region is gaining tract

article thumbnail

Trial finds benefit for GLP-1 agonist in Parkinson’s

pharmaphorum

A small study of Sanofi’s lixisenatide has suggested that the GLP-1 agonist could slow down the progression of Parkinson’s disease, pointing to another potential use for the fast-growing drug class.

107
107
article thumbnail

H5N1 avian flu found in Texas individual who apparently was infected by dairy cows

STAT

Texas health officials reported Monday that an individual who had been in contact with cattle has contracted H5N1 avian flu, only the second case ever recorded in the U.S. The person had contact with dairy cattle that are believed to have been infected with the virus, the Texas Department of State Health Services said in a statement. It went on to say that the individual’s only symptom is eye inflammation — infection of the conjunctiva, the tissue surrounding the eye.

364
364
article thumbnail

Viral return: 3 U.S. cases concerning experts

PharmaVoice

Infectious diseases that were “off the playing field” are now making a comeback.

204
204
article thumbnail

Bristol Myers CAR-T therapy approved by FDA for earlier myeloma use

BioPharma Dive

The FDA’s clearance comes three weeks after a panel of advisers endorsed expanded use of Abecma despite safety concerns raised by the agency.

117
117
article thumbnail

Ed Schoonveld Discusses List Prices for Pharmaceuticals in the US Compared to Other Countries

Pharmaceutical Commerce

In an interwith with Pharma Commerce Editor Nicholas Saraceno, Ed Schoonveld, Value and Access Advisor, Schoonveld Advisory, explains why pharmaceutical products tend to cost more in the US than the rest of the world.

105
105
article thumbnail

New HHS guidance requires consent for pelvic, breast, and other sensitive examinations

STAT

Hospitals performing pelvic and other sensitive exams for training purposes without patients’ explicit consent, including on anesthetized patients, won’t be eligible for Medicare and Medicaid reimbursement, according to new guidance released on Monday by the Department of Health and Human Services’ Centers for Medicare and Medicaid Services.

Hospitals 363
article thumbnail

With an ovarian KRAS combo ready for review, Verastem’s CEO is poised for the transition

PharmaVoice

As its FDA filing approaches, Verastem Oncology CEO Daniel Paterson wants to go from “The Little Engine That Could” to a major oncology player.

147
147
article thumbnail

SAVA Healthcare to set up second plant in Indore

Express Pharma

First phase with a builtup area of 29,000 square meters to be completed within a year, second phase by 2026 Gujarat-based SAVA Healthcare conducted the ground-breaking ceremony of its second manufacturing plant, in the Smart Industrial Park (SIP) of Madhya Pradesh Industry Development Corporation (MPIDC) in March. This green field project will expand the manufacturing capabilities of SAVA Healthcare as well as create 1000+ job opportunities, offering advanced skill development for the local tale

105
105
article thumbnail

Key mechanism controlling bone marrow stem cells could lead to new therapies

Pharma Times

Hoxa9 and b-catenin molecules are a rare population of self-renewing HSCs found in bone marrow

138
138
article thumbnail

Opinion: Banning teens from social media won’t help their mental health. Here’s what might

STAT

Since the U.S. surgeon general’s 2023 advisory on social media and teen mental health, public concern has skyrocketed around adolescents’ digital lives. Major news organizations and even state governments have pinned social media apps as addictive , dangerous, and the cause of the youth mental health crisis. In turn, calls to ban teens from social media apps have started to emerge, with mixed reception from policymakers nationwide.

363
363
article thumbnail

What Do The 2023 NAPLEX Pass Rates Mean For 2024?

Med Ed 101

The North American Pharmacist Licensure Examination (NAPLEX) is the clinical exam that allows a pharmacy graduate to become a licensed pharmacist. The NAPLEX is designed to evaluate your knowledge of pharmacy practice and is required for pharmacist licensure. It is a 6-hour exam composed of 225 questions, and students are allowed 5 attempts to pass […] The post What Do The 2023 NAPLEX Pass Rates Mean For 2024?

105
105
article thumbnail

SOPHiA GENETICS partners with Strand Life Sciences

Express Pharma

The companies will join forces to advance the use of precision medicine on a global scale SOPHiA GENETICS, a cloud-native software company in the healthcare space has announced a strategic partnership with Strand Life Sciences to deliver innovative solutions that will fuel the use of precision medicine globally. The new collaboration will leverage the industry-leading strengths from both companies to provide access to advanced genomics technologies, cutting-edge bioinformatics services and inno

105
105
article thumbnail

Securing the future: Innovating pharmaceutical supply chain for resilience and safety

pharmaphorum

Explore the innovative use of artificial intelligence (AI) and machine learning (ML) in securing the pharmaceutical supply chain for resilience and safety. Learn how cutting-edge technology is shaping the future of pharmaceutical logistics.

106
106
article thumbnail

STAT+: Biden administration sticks with slight cuts to 2025 Medicare Advantage payments

STAT

Over the past few weeks, Medicare Advantage insurers demanded that the Biden administration give them higher payment rates for next year. The government’s data on how much people were using health care didn’t match their own data, insurers and lobbyists griped — and therefore they wouldn’t be paid enough to cover those costs.

Hospitals 359
article thumbnail

Biosimilar Competition Does Not Reduce Patient Out-of-Pocket Costs for Biologic Drugs

Drug Patent Watch

A recent study published in JAMA Health Forum sheds light on the impact of biosimilar competition on patient out-of-pocket (OOP) costs for biologic drugs in the United States.

article thumbnail

Q12024 funding in pharma, healthcare dips 70% from Q4 2023

Express Pharma

As per Tracxn.com data, 58.5 per cent of funding in Q12024 in early-stage rounds Total funding in the healthtech, lifesciences and healthcare space was $180 million in Q1 2024, a slight drop of 4 per cent from Q1 2023, but a sharp decline of 70 per cent when compared with Q4 2023. This sector raised $187 million and $607 million in Q1 2023 and Q4 2023 respectively.

105
105
article thumbnail

Praia emerges with $20m for digital health platform

pharmaphorum

Healthcare system Providence has spun out a new company, Praia Health, focused on a platform to build and sustain connections between patients and health providers. The new company starts life with $20 million in Series A funding and a mission to develop the Praia Health Identity and Engagement Platform, which was launched within Providence’s digital innovation group (DIG) incubator in 2022 and already handles around 3.5 million user accounts.

104
104
article thumbnail

STAT+: Amylyx to pull ALS drug from market, cut 70% of staff

STAT

Amylyx Pharmaceuticals will take its ALS drug Relyvrio off the market in the U.S. and Canada, ending a multi-year saga for patients with the rare neurodegenerative disease. Relyvrio was approved by the Food and Drug Administration in 2022 , based on data that showed a modest slowing of disease progression. The approval was contentious — regulators initially advised Amylyx not to file for approval until it had conducted another test, but ultimately cleared the drug.

348
348
article thumbnail

2024 KDIGO Guidelines: The MOST Important Medication Recommendations

Med Ed 101

The Kidney Disease: Improving Global Outcomes (KDIGO) organization has released an updated April 2024 clinical practice guideline for the evaluation and management of Chronic Kidney Disease (CKD). The new 2024 KDIGO guidelines include 6 chapters dedicated to the evaluation of CKD, risk assessment in people with CKD, management to delay CKD progression and manage its […] The post 2024 KDIGO Guidelines: The MOST Important Medication Recommendations appeared first on Med Ed 101.

105
105
article thumbnail

Bora Pharmaceuticals acquires Upsher-Smith

Express Pharma

The acquisition expands Taiwan-based Bora’s North American footprint with its first US manufacturing site Bora Pharmaceuticals (Bora) completed the acquisition of Upsher-Smith Laboratories (Upsher-Smith), a generics manufacturer and marketer based in Minnesota, US, from its sellers, Sawai Group Holdings and Sumitomo Corporation of Americas. Upsher-Smith, founded in 1919, has a diversified portfolio of 48 generic products with manufacturing facilities in Plymouth and Maple Grove, Minnesota.

Dosage 105
article thumbnail

FDA Tells Congress What It Wants, What it Really Really Wants (it really really really wants a zigazig-ah)

FDA Law Blog: Biosimilars

By Sara W. Koblitz — Every year, federal agencies submit a budget request to Congress to fund various agency initiatives, and every year FDA includes a list of legislative proposals that it would like to see come out of Congress. This year is no different , and in fact some of the requests on this year’s list are repeat offenders from last year’s. And though FDA may not have gotten everything that it wanted last year, reviewing and reflecting on these lists of legislative proposals provides im

Labelling 104